Validant Acquires DataRevive

Validant Acquires Greenleaf Health

April 23, 2021

Healthcare Services

Validant, a PE-backed global quality, compliance and regulatory consulting group, has acquired Greenleaf Health, a Washington, D.C.-based FDA regulatory consulting firm. Concurrent with the acquisition, Greenleaf founder Patrick Ronan was named CEO of Validant as the combined group expands its regulatory and quality capabilities supported by GHO Capital.

Validant Acquires IDEC to Establish Presence in Japan

December 2, 2020

Healthcare Services

Validant, a GHO Capital-backed quality, compliance and regulatory consulting group, has acquired IDEC, a Japan-based regulatory consultancy led by Naoya Kato. The acquisition gives Validant a Tokyo presence, expands its regulatory and implementation capabilities in Asia, and complements its earlier DataRevive acquisition to build a broader pan-Asian regulatory practice.

ELIQUENT Life Sciences Acquires Truliant Consulting

April 2, 2025

Healthcare Services

ELIQUENT Life Sciences has acquired Truliant Consulting, a Baltimore-based pharmacovigilance, risk management, and regulatory compliance advisory firm. The acquisition expands ELIQUENT's pharmacovigilance platform and capabilities to provide broader, technology-driven, and scalable safety and regulatory solutions to life sciences clients.

VTG Acquires Next Rev Technologies, LLC

November 15, 2022

IT Services

VTG has acquired Next Rev Technologies, LLC to expand its multi-cloud software development, digital transformation, and cyber capabilities while adding Next Rev's U.S. Intelligence Community customers. The acquisition enhances VTG's data science and advanced analytics depth and supports its strategy to build a mid-tier national security company.

Crown Laboratories Acquires Revance Therapeutics

August 12, 2024

Biotechnology

Crown Laboratories, a Hildred Capital portfolio company, completed the acquisition of Revance Therapeutics through a cash tender offer that expired February 4, 2025; the transaction closed on February 6, 2025 and Revance will be delisted from Nasdaq. The deal brings together Crown's skincare and consumer brands with Revance's DAXXIFY, RHA dermal fillers and other aesthetics/therapeutic offerings to expand product portfolio and commercialization capabilities across medical, retail and e-commerce channels.

Validant (GHO-backed) Acquires Oriel STAT A MATRIX

April 15, 2021

Healthcare Services

Validant, a transatlantic quality, compliance and regulatory consulting group and portfolio company of GHO Capital, has acquired Oriel STAT A MATRIX, a New Jersey–headquartered consultancy and training firm serving the medical device, IVD and combination product markets. The deal expands Validant’s capabilities into training services and deepens its regulatory consulting bench as part of an international add-on growth strategy.